Brief Research Report
Published on 17 Jul 2023
BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
in Hematologic Malignancies
- 3,430 views
- 1 citation
Brief Research Report
Published on 17 Jul 2023
in Hematologic Malignancies
Editorial
Published on 13 Jul 2023
in Hematologic Malignancies
Review
Published on 13 Jul 2023
in Hematologic Malignancies
Original Research
Published on 05 Jul 2023
in Hematologic Malignancies
Original Research
Published on 04 Jul 2023
in Hematologic Malignancies
Mini Review
Published on 03 Jul 2023
in Hematologic Malignancies
Case Report
Published on 28 Jun 2023
in Hematologic Malignancies
Editorial
Published on 27 Jun 2023
in Hematologic Malignancies
Review
Published on 27 Jun 2023
in Hematologic Malignancies
Review
Published on 23 Jun 2023
in Hematologic Malignancies
Original Research
Published on 23 Jun 2023
in Hematologic Malignancies
Original Research
Published on 23 Jun 2023
in Hematologic Malignancies
Brief Research Report
Published on 22 Jun 2023
in Hematologic Malignancies
Editorial
Published on 19 Jun 2023
in Hematologic Malignancies
Editorial
Published on 16 Jun 2023
in Hematologic Malignancies
Original Research
Published on 16 Jun 2023
in Hematologic Malignancies